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Microsporidia are a group of obligate intracellular parasites that naturally infect
domestic and wild animals. Human microsporidiosis is an increasingly recognized
multisystem opportunistic infection. The clinical manifestations are diverse with
diarrhea being the most common presenting symptom. We present a 52-year-old
woman with a history of amyopathic dermatomyositis complicated by interstitial lung
disease managed with mycophenolate mofetil and hydroxychloroquine who pres-
ented with a 7-month history of recurrent subcutaneous nodules as well as intermit-
tent diarrhea and chronic sinusitis. A punch biopsy showed superficial and deep
lymphocytic and granulomatous dermatitis with focal necrosis. Tissue stains for
microorganisms revealed oval 1 to 3 μm spores within the necrotic areas in multiple
tissue stains. Additional studies at the Centers for Disease Control and Prevention
confirmed cutaneous microsporidiosis. This case is one of very few confirmed exam-
ples of cutaneous microsporidiosis reported in the literature.
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1 | INTRODUCTION
Microsporidia are a group of obligate intracellular organisms, which
typically cause limited intestinal disease in immunosuppressed
patients, especially in those with advanced human immunodeficiency
virus/acquired immunodeficiency syndrome (HIV/AIDS). The extra-
intestinal manifestations of microsporidiosis are diverse and include
cardiac, pulmonary, ocular, and renal disease.1-5
Microsporidia were previously considered protozoa but have
since been reclassified as fungi based on spore size, nucleus arrange-
ment, mode of replication, and rRNA analysis.2,5 Over 1200 species
have been identified, 15 of which have been reported as human path-
ogens.6 The most common species infecting humans is Enterocytozoon
bieneusi, followed by the Encephalitozoon species (particularly
Encephalitozoon intestinalis). Enterocytozoon infections normally cause
localized infection; in contrast, Encephalitozoon species have the abil-
ity to disseminate widely via macrophages, thus causing systemic
infection involving the intestinal and hepatobiliary tracts, respiratory
tract, sinuses, kidney, eye, brain, and skin.2,5,6 Anncaliia algerae has
also been implicated in infections of the eye, skeletal muscle, and skin
of humans.6
Transmission is not completely understood, but is thought to
occur primarily by ingestion or inhalation of spores.1,5 Diagnosis can
be achieved via light microscopy, transmission electron microscopy
(TEM), immunofluorescence and immunohistochemical assays with
polyclonal or monoclonal antibodies, cell culture, and polymerase
chain reaction (PCR).2,3,7-9 Intestinal biopsy reveals distorted villous
architecture, including blunting and hyperplasia of crypts and lack of
an inflammatory response.1,2 Cutaneous involvement in dissemi-
nated microsporidiosis presents as painful, erythematous, scaly, and
crusted skin nodules. Skin biopsy showed a dense dermal acute and
granulomatous inflammatory reaction with presence of many
spores.3 Erythematous macules and papules with histopathologic
confirmation of involvement by microsporidia has also been reported
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in an immunocompromised patient.4 Spores may be highlighted with
a number of different stains, including the modified trichrome/chro-
motrope 2R, acid-fast, periodic acid-Schiff, and Warthin-Starry
stains.7 These stains can be used on stool, urine, and respiratory
specimens. TEM can identify substructural characteristics, such as
number of polar filament cross sections, arrangement of polar fila-
ments, and characteristics of the parasite-host interface, to differen-
tiate among species.5
2 | CASE REPORT
A 52-year-old, HIV-negative female from rural Indiana presented
with a 7-month history of recurrent subcutaneous nodules on her
face, arms, and legs. Her past medical history was significant
for amyopathic dermatomyositis complicated by interstitial lung
disease, which was managed with mycophenolate mofetil and
hydroxychloroquine. On examination, the lesions appeared as 1 to
1.5 cm subcutaneous flesh-colored nodules distributed diffusely.
Some lesions had an erythematous-violaceous hue, and older
lesions exhibited a central hyperkeratotic plug (Figure 1).
Previous biopsies on two separate occasions (January and
April 2016), which were interpreted at another facility, showed a lym-
phoid infiltrate consistent with cutaneous lymphoid hyperplasia in the
initial biopsy, and a necrotizing vasculitis involving medium-sized ves-
sels with associated granulomatous inflammation in the subsequent
biopsy. At that time, Giemsa and Fite stains were negative for infec-
tious microorganisms. As the differential included granulomatosis with
polyangiitis, the patient was treated with a 6-week prednisone taper,
with initial mild improvement of the skin lesions. A review of those
biopsies in our institution showed presence of microorganisms consis-
tent with microsporidia in the biopsy from April 2016 but not in the
biopsy from January 2016. The vasculitis evident in the April 2016
biopsy was subsequently regarded as a secondary phenomenon to the
infectious process rather than a primary vasculitis because vasculitis
has not been reported in localized or disseminated microsporidiosis to
our knowledge.
Her skin nodules recurred once again, and punch biopsies were
taken from nodules on the right lateral leg and left posterior leg in our
institution in June 2016. Hematoxylin and eosin stain showed a
F IGURE 1 A and B, Diffuse flesh-colored subcutaneous nodules.
Note the subtle overlying erythema of an early subcutaneous
nodule in A, while B reveals the older lesions with central
hyperkeratotic plugs
F IGURE 2 A and B, Biopsy from
the left posterior leg. Lymphocytic
infiltration within the dermis and
subcutaneous tissues. Note the area
of focal necrosis within the dermis
(arrow), A, in which microorganisms
consistent with microsporidia were
present (arrows), B, Hematoxylin and
eosin (H&E). A, original magnification
×2.5, B, original magnification ×100
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superficial and deep lymphocytic and granulomatous dermatitis with
focal necrosis (Figure 2). Tissue stains for microorganisms revealed
1 to 3 μm, round to oval structures within the necrotic areas, best
highlighted by Giemsa, Steiner, and Fite stains (not shown). Additional
studies were performed at the Centers for Disease Control and Pre-
vention (CDC) and confirmed the presence of microsporidia species. A
Gomori methenamine silver (GMS) stain (Figure 3A) and an immuno-
histochemical stain by using rabbit anti-Encephalitozoon cuniculi serum
(Figure 3B) highlighted the spores. L-T Gram was also performed
(Figure 3C) and polarization of the slide revealed bright white spores
(Figure 3D). Electron microscopy identified diplokaryotic organisms
containing up to 12 coils of polar tubules in two rows in anisofilar
arrangement (Figure 4A,B), confirming microsporidia species. Specia-
tion was determined by PCR to be A. algerae, formerly known as
Nosema and Brachiola.
Further questioning revealed that the patient experienced an epi-
sode of diarrhea 6 months prior to the onset of cutaneous lesions,
which lasted ~10 days and resulted in a 25-35-pound weight loss. She
also had recurrent sinusitis throughout this time. She denied a history
of travel preceding her symptoms. The patient reported exposure to
domestic pets and wild animals near her home, representing the most
probably infectious reservoir. We hypothesized that ingestion of spores
resulted in primary gastroenteritis with subsequent hematogenous dis-
semination to the skin facilitated by immunosuppressive drugs.
F IGURE 3 A-D, Tissue stains for
microorganisms. A, Gomori
methenamine silver (GMS) stain
showing Anncaliia algerae spores
(arrow) (original magnification
×100). B, Immunohistochemical
staining of spores (red) in same area
shown in Figure 2A; naphthol fast red
substrate with hematoxylin
counterstain (original magnification
×100). C, L-T Gram stain highlights
Gram-positive spores (arrow) (original
magnification ×100). D, Polarization
of the same field in (C) showing bright
white spores (arrow) (original
magnification ×100)
F IGURE 4 A and B, Electron microscopic images of Anncaliia algerae spores. Note cross sections of the polar tubule (arrows) in two rows in
an anisofilar arrangement, which allowed for confirmation of microsporidia species. N, nucleus. Ex, exospore. En, endospore. Bars, 0.5 μm
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The patient was discontinued from mycophenolate mofetil
and was placed on a 21-day course of albendazole, with improvement
in her skin lesions. She returned to Indiana for her follow-up care.
3 | DISCUSSION
Microsporidia infection frequently begins with gastrointestinal mani-
festations, which may distort villous architecture and lead to diarrhea
and malabsorption.1,2 In addition, microsporidia may disseminate from
the intestinal tract and result in numerous other clinical manifesta-
tions, particularly in immunocompromised patients. These manifesta-
tions may include upper respiratory symptoms, acute kidney injury,
encephalitis, myositis, and, in very rare cases, subcutaneous nodular
disease.1-4,6 Our patient's immunosuppression by mycophenolate
mofetil probably predisposed her to microsporidia infection, most
probably from the animals to which she was exposed. We believe this
began with gastrointestinal symptoms, although her infection proba-
bly disseminated hematogenously early on, resulting in sinusitis-like
symptoms and cutaneous nodules. The steroid taper, although initially
resulting in mild improvement, probably worsened her disseminated
disease state because of further immunosuppression. In fact, two prior
reports describe worsening microsporidiosis with steroid use.4,10
To the best of our knowledge, only three other examples of
microsporidial infection with nodular skin lesions have been reported
in the literature. One of these cases occurred in a patient with late-
stage HIV and a history of chronic sinusitis.3 Another case occurred in
a patient with chronic lymphocytic leukemia.11 As in our patient,
microsporidia infection was originally not considered a likely etiology
because initial tissue stains for microorganisms were negative for an
infectious cause. In this previously published case, the subcutaneous
nodules were later associated with adjacent osteomyelitis. This sug-
gests that microsporidia organisms can be locally destructive, resulting
in a severe infection. Therefore, cutaneous microsporidia infections
should be diagnosed and treated promptly in order to prevent such a
harmful sequela. Both this report and our case illustrate the difficulty
in identifying microsporidia on conventional staining. Immunohisto-
chemical stains for microorganisms and electron microscopy have
been shown to be highly effective and definitive in identifying these
organisms in a timely manner.8,9,12 DNA amplification studies are also
important in confirming infection.13
Another report of subcutaneous nodules associated with micro-
sporidia infection occurred in a patient who was immunosuppressed
with fludarabine, cyclophosphamide, alemtuzumab, and cyclosporine
after undergoing an autologous stem cell transplant for multiple mye-
loma.4 This patient experienced pulmonary manifestations in addition
to cutaneous findings. As in the case of our patient, the microsporidia
organisms were initially not seen on staining. The patient was treated
with systemic steroids, which resulted in initial mild improvement but
eventual worsening of the infection.4 The patient ultimately died of
pulmonary-related manifestations. Similar to our case, this example
highlights the difficulty in diagnosing microsporidia infection and the
risks of inadvertently using steroids to manage such cases.
Further speciation of organisms in these two prior cases of cuta-
neous microsporidia disease revealed E. intestinalis in the patient with
HIV14 and Tubulinosema acridophagus in the patient with multiple
myeloma.4 Neither of these organisms was present in our patient;
instead, A. algerae was confirmed by PCR. A. algerae infection has
been shown to be associated with severe myositis in immunocompro-
mised patients15-17; however, to date, no examples of subcutaneous
nodules secondary to A. algerae microsporidial infection have been
described. One example of a skin abscess associated with A. algerae
infection was reported in an immunosuppressed patient receiving che-
motherapy; however, diffuse nodular disease, as was present in our
patient, has not been reported.18
Although albendazole is the treatment of choice in patients with
most species of microsporidial infections, specific efficacy against
A. algerae has not been studied.13,15 Our patient's skin lesions
improved significantly with albendazole, suggesting that it is indeed
an effective treatment option for A. algerae.
Our case illustrates the benefit of taking a full review of systems
and complete history in immunocompromised patients with skin
diseases. The fact that this patient had exposure to animals along
with an extensive history of diarrhea and sinusitis proved to be key
information in identifying potential etiologies of her disease.
This case report is extraordinary in that it describes one of only a
handful of cases of confirmed cutaneous microsporidiosis. It also
emphasizes the difficulty in diagnosing systemic microsporidial
disease. It highlights the fact that the use of multiple different histo-
chemical stains can assist with the identification of these microor-
ganisms; once identified, uniformity in size and structure is highly
suggestive of the presence of microorganisms. Ancillary studies, such
as immunohistochemistry, electron microscopy, and PCR can be
helpful in confirming the diagnosis and aid the clinician in selecting
the appropriate treatment for the patient. Disseminated micro-
sporidia infection should be considered as a possible differential
diagnosis in all immunocompromised patients with skin nodules and
recent gastrointestinal disease.
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